1. Home
  2. FPI vs ZURA Comparison

FPI vs ZURA Comparison

Compare FPI & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$10.46

Market Cap

503.5M

Sector

Real Estate

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$4.31

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
ZURA
Founded
2013
2022
Country
United States
United States
Employees
N/A
40
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
455.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
FPI
ZURA
Price
$10.46
$4.31
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
N/A
$13.00
AVG Volume (30 Days)
321.1K
630.2K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
3.14%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$52,178,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1,049.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$0.99
52 Week High
$13.23
$7.25

Technical Indicators

Market Signals
Indicator
FPI
ZURA
Relative Strength Index (RSI) 41.47 36.89
Support Level $10.14 $3.33
Resistance Level $10.58 $4.58
Average True Range (ATR) 0.18 0.32
MACD 0.04 -0.01
Stochastic Oscillator 51.14 28.16

Price Performance

Historical Comparison
FPI
ZURA

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: